AI Article Synopsis

  • 3-Methylcholanthrene (MC) activates the aryl hydrocarbon receptor, increasing CYP1A1 expression while decreasing CYP2C11 and other male-specific genes that are regulated by pulsatile growth hormone (GH) through STAT5b.
  • MC significantly enhances certain hepatic P450 enzyme activities, including a notable induction of CYP1A1, while simultaneously reducing protein and mRNA levels of CYP2D9 and CYP3A.
  • These findings suggest that MC alters gene expression through mechanisms that disrupt GH signaling, particularly affecting male-specific genes linked to GH and STAT5b regulation.

Article Abstract

3-Methylcholanthrene (MC) activates the aryl hydrocarbon receptor and increases expression of cytochrome P450 (P450) enzymes such as CYP1A1. MC also decreases expression of CYP2C11, the major hepatic P450 in male rats that is regulated by pulsatile growth hormone (GH) secretion via a pathway partially dependent on signal transducer and activator of transcription 5b (STAT5b). If disruption of this GH signaling pathway is important for MC's ability to suppress CYP2C11 transcription, we hypothesize that MC suppresses other male-specific genes (e.g., mouse Cyp2d9) regulated by pulsatile GH with STAT5b dependence. We examined the time course of MC's effects on hepatic P450s and GH signaling components in male C57BL/6 mice. P450 content, heme content, and NADPH P450 oxidoreductase activity were induced 2.3-, 1.8-, and 1.3-fold, respectively, by MC. MC dramatically induced CYP1A1 mRNA, protein, and catalytic activity. MC caused a 42% decrease in CYP2D9 protein, a 28% decrease in CYP2D9 mRNA, and a 27% decrease in testosterone 16alpha-hydroxylation activity. MC caused a pronounced decrease in CYP3A protein; however, there was no apparent change in testosterone 6beta-hydroxylation activity, and changes in mRNA levels for CYP3A forms were relatively small. Expression of GH receptor and major urinary protein 2, a gene regulated by GH with STAT5b dependence, was decreased by MC at the mRNA level. These results show that MC suppresses mouse Cyp2d9, a pulsatile GH- and STAT5b-dependent male-specific gene, via a pretranslational mechanism that may involve disrupted GH signaling. Mouse CYP3A protein levels are dramatically decreased by MC via a mechanism that is not yet understood.

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.106.009936DOI Listing

Publication Analysis

Top Keywords

growth hormone
8
signaling components
8
regulated pulsatile
8
mouse cyp2d9
8
stat5b dependence
8
activity caused
8
decrease cyp2d9
8
cyp3a protein
8
p450
6
protein
5

Similar Publications

Basal and stimulated inhibin B in pubertal disorders.

J Clin Endocrinol Metab

January 2025

3Department of Metabolism, Digestion and Reproduction, Imperial College London.

Pubertal disorders in the form of delayed puberty (DP) or precocious puberty (PP) can cause considerable anxiety to both children and parents. Since the clinical and biochemical signatures of self-limiting and permanent conditions overlap considerably, it can be hard to determine whether to offer them reassurance or intervention. Researchers have thus long been searching for a robust test to indicate that the process of endogenous puberty is underway and is likely to proceed to completion.

View Article and Find Full Text PDF

Loss-of-function GHSR variants are associated with short stature and low IGF-I.

J Clin Endocrinol Metab

January 2025

Division of Pediatric Endocrinology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, The Netherlands.

Context: The growth hormone (GH) secretagogue receptor, encoded by GHSR, is expressed on somatotrophs of the pituitary gland. Stimulation with its ligand ghrelin, as well as its constitutive activity, enhances GH secretion. Studies in knock-out mice suggest that heterozygous loss-of-function of GHSR is associated with decreased GH response to fasting, but patient observations in small case reports have been equivocal.

View Article and Find Full Text PDF

A weight of evidence review on the mode of action, adversity, and the human relevance of xylene's observed thyroid effects in rats.

Crit Rev Toxicol

January 2025

Product Stewardship, Science & Regulatory, Shell Global Solutions International B.V. The Hague, the Netherlands.

Xylene substances have wide industrial and consumer uses and are currently undergoing dossier and substance evaluation under Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) for further toxicological testing including consideration of an additional neurotoxicological testing cohort to an extended one-generation reproduction toxicity (EOGRT) study. New repeated dose study data on xylenes identify the thyroid as a potential target tissue, and therefore a weight of evidence review is provided to investigate whether or not xylene-mediated changes on the hypothalamus-pituitary-thyroid (HPT) axis are secondary to liver enzymatic induction and are of a magnitude that is relevant for neurological human health concerns. Multiple published studies confirm xylene-mediated increases in liver weight, hepatocellular hypertrophy, and liver enzymatic induction the oral or inhalation routes, including an increase in uridine 5'-diphospho-glucuronosyltransferase (UDP-GT) activity, the key step in thyroid hormone metabolism in rodents.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Libin Cardiovascular Institute, Calgary, AB, Canada; Hotchkiss Brain Institute, Calgary, AB, Canada; University of Calgary, Calgary, AB, Canada.

There is growing recognition that exercise is a potent stimulus for improving cognitive and brain function in both humans and rodents. While the mechanisms underlying the effect of exercise on cognition are very likely multifactorial, it is clear that the secretion and function of several classical factors are involved. Work done in rodents implicates several growth factors, including BDNF, IGF-1, and VEGF, in the ability of exercise to induce neuroplastic changes within key brain regions associated with learning and memory.

View Article and Find Full Text PDF

Background: Growth hormone-secreting pituitary adenomas (GHPA) display diverse biological behaviors and clinical outcomes, necessitating the identification of tumor heterogeneity and prognostically relevant markers.

Methods: In this study, we performed single-cell RNA sequencing (scRNA-seq) on 10 GHPA samples, four of which also underwent spatial transcriptome sequencing, and used scRNA-seq data from four normal pituitary samples as controls. Cell subtype characterization in GHPA was analyzed using multiple algorithms to identify malignant bias regulators, which were then validated using a clinical cohort.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!